Beta Bionics (BBNX) Total Non-Current Liabilities (2023 - 2026)

Beta Bionics has disclosed Total Non-Current Liabilities across 4 years of filings, most recently posting $34.4 million for Q2 2026.

• In Q2 2026, Total Non-Current Liabilities rose 25.85% year-over-year to $34.4 million; the TTM figure through Jun 2026 stood at $34.4 million (up 25.85% YoY), while the FY2025 annual figure was $39.6 million, up 37.77% from the prior year.
• Total Non-Current Liabilities came in at $34.4 million for Q2 2026 at Beta Bionics, up from $31.6 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $39.6 million in Q4 2025 to a low of $13.9 million in Q4 2023.
• Average Total Non-Current Liabilities over 4 years is $29.2 million, with a median of $30.2 million recorded in 2024.
• Year-over-year, Total Non-Current Liabilities jumped 107.33% in 2024 and rose 25.85% in 2026.
• Over 4 years, Total Non-Current Liabilities stood at $13.9 million in 2023, then soared by 107.33% to $28.7 million in 2024, then soared by 37.77% to $39.6 million in 2025, then slipped by 13.12% to $34.4 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $34.4 million in Q2 2026, $31.6 million in Q1 2026, and $39.6 million in Q4 2025.